{
  "id": 714,
  "text": "0 5 } ^ { \\cdot }$ ).There were no port-site recurrence, nor was there a difference in the pattern of recurrences between the two procedures.In the identified study694 comparing VALRH and LARVH, no difference with respect to the 5- year recurrence-free survival rate and OS for FIGO stage IB1 cervical cancer were reported ( $9 2 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 0 5 } ^ { \\cdot }$ ).There were no port-site recurrence, nor was there a difference in the pattern of recurrences between the two procedures.In the identified study694 comparing VALRH and LARVH, no difference with respect to the 5- year recurrence-free survival rate and OS for FIGO stage IB1 cervical cancer were reported ( $9 2 .\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据现有研究，对比腹腔镜根治性子宫全切除术（LARVH）和阴式腹腔镜辅助根治性子宫全切除术（VALRH）治疗FIGO IB1期宫颈癌，这两种手术方式在5年无复发生存率（RFS）和总体生存率（OS）方面未表现出显著差异。这表明两种手术方式在与肿瘤复发和患者生存结局相关的疗效上可以认为是相当的。",
  "query": "在比较腹腔镜根治性子宫全切除术和阴式腹腔镜辅助根治性子宫全切除术治疗FIGO IB1期宫颈癌时，这两种手术方式在5年无复发生存率和总体生存率方面是否存在显著差异？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在比较腹腔镜根治性子宫全切除术和阴式腹腔镜辅助根治性子宫全切除术治疗FIGO IB1期宫颈癌时，这两种手术方式在5年无复发生存率和总体生存率方面是否存在显著差异？\n\n<reference text>: 0 5 } ^ { \\cdot }$ ).There were no port-site recurrence, nor was there a difference in the pattern of recurrences between the two procedures.In the identified study694 comparing VALRH and LARVH, no difference with respect to the 5- year recurrence-free survival rate and OS for FIGO stage IB1 cervical cancer were reported ( $9 2 .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据现有研究，对比腹腔镜根治性子宫全切除术（LARVH）和阴式腹腔镜辅助根治性子宫全切除术（VALRH）治疗FIGO IB1期宫颈癌，这两种手术方式在5年无复发生存率（RFS）和总体生存率（OS）方面未表现出显著差异。这表明两种手术方式在与肿瘤复发和患者生存结局相关的疗效上可以认为是相当的。"
}